Yes — SMART therapy has an excellent long-term safety profile supported by over a decade of clinical trial data. The ICS component (inhaled corticosteroid) is the same as used in traditional controller therapy — delivered more intelligently, with every rescue puff also providing anti-inflammatory coverage. In Delhi’s high-pollution environment, SMART therapy is particularly well-suited because the as-needed rescue puffs on high-AQI days provide additional anti-inflammatory cover precisely when the inflammation burden is highest. Dr. Dixit Kumar Thakur monitors all Pulmovista patients on SMART therapy with regular spirometry and FeNO review to ensure optimal dosing over time.